L. Wendland
Papers
1
Total Citations
18
H-Index
1
About
Dr. L. Wendland is a leading figure in the advancement of boron neutron capture therapy (BNCT), a cutting-edge form of radiation oncology. Their primary research focuses on the clinical translation and optimization of BNCT, particularly for treating aggressive cancers. Dr. Wendland’s most significant contribution is the comprehensive review of 249 patients treated with BNCT at Helsinki University Hospital, a landmark study that provides critical long-term efficacy and safety data from the Finnish experience using reactor-based neutrons and l-BPA-F. This work, which has garnered 18 citations, has been instrumental in demonstrating BNCT’s clinical viability and informing its transition from nuclear reactor-based systems to modern, hospital-based proton accelerator sources. By synthesizing over a decade of clinical outcomes, Dr. Wendland has provided the foundational evidence needed to guide the next generation of BNCT trials and technologies, solidifying their role as a key translator of this innovative therapy from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1